The global Oncology Informatics market is forecasted to be worth USD 8.01 Billion by 2027, according to a current analysis by Emergen Research. The oncology informatics market is growing due to an increase in the number of cancer patients and the rise in the adoption of advanced technologies.
The integration of oncology informatics with Blockchain technology and increasing investment opportunities in the developing and developed nations such as Brazil, and China, coupled with advancement in the precision medicine technology, are some of the opportunities that will drive the market technology in the coming years. However, despite these benefits, some of the challenges of the market are the dearth of a medical oncologist, the high cost of installation and lack of interoperability. Concerns regarding the data security concerns will also hinder the demand for the product.
To help gain the business owner further gain business intelligence the study on the Oncology Informatics market for the forecast period 2020 - 2027 brings to light data on production capability, consumption capacity, spending power, investment feasibility, and technology innovation. A thorough assessment of market performance across different regions is presented through self-explanatory graphic images, charts, and tables that add weight to corporate presentations and marketing materials. The study offers regional profiles of major vendors and extensive country-level break down to empower companies to make a wise investment decision when exploring new regions.
Read more@ https://www.emergenresearch.com/industry-report/oncology-informatics-market
Key Highlights From The Report
In June 2020, Philips announced a collaboration with MD Anderson’s Precision Oncology Decision Support (PODS) system to allow the physicians globally to personalize therapy based on the patient’s genomic profile to improve patient care.
PHM or population health management is applied to chronic disease management with extensive data analysis. The purpose of the process is to enhance the patient outcome and overall cost. The information helps in developing actionable treatment steps for individual or specific groups.
Pharmaceutical organizations are primary end-users of the oncology informatics market due to the usage of the solutions, which will increase the workflow of the facilities and enhance the quality of care.
The Asia Pacific region is anticipated to be seeing substantial growth as a result of changes in lifestyles. The increasing incidence of cancer among people is anticipated to propel the cancer immunotherapy market's growth on a global scale. The cancers with the highest levels of mutations include melanoma, lung, bladder, stomach, and esophageal cancer, and it is highly prevalent in the Asia Pacific region.
Key participants include Elekta AB, Hologic, Inc., Cerner Corporation, F. Hoffmann-La Roche Ltd., Inspirata, Inc., IBM Corporation, Laboratory Corporation of America Holdings, Koninklijke Philips N.V., PerkinElmer, Inc., and McKesson Corporation, among others.
Request For Free Sample@ https://www.emergenresearch.com/request-sample/384
Type Outlook (Revenue, USD Billion; 2017-2027)
Population Health Management (PHM)
Drug Discovery and Development Informatics
Electronic Health Records (EHRs)
Clinical Decision Support System (CDSS)
Image Analytics
End Users Outlook (Revenue, USD Billion; 2017-2027)
Life Science Industry
Academic Institutes and Research Centers
Pharmaceutical Industry
Contract Research Organizations (CROs)
Others (Hospitals and Other Care Facilities)
Regional Outlook (Revenue, USD Billion; 2017-2027)
North America
Europe
Asia Pacific
Latin America
MEA
Table of Content
Chapter 1. Methodology & Sources
1.1. Oncology Informatics Market Definition
1.2. Oncology Informatics Market Research Scope
1.3. Oncology Informatics Market Methodology
1.4. Oncology Informatics Market Research Sources
1.4.1. Primary
1.4.2. Secondary
1.4.3. Paid Sources
1.5. Oncology Informatics Market Estimation Technique
Chapter 2. Executive Summary
2.1. Summary Snapshot, 2019-2027
Chapter 3. Key Insights
Chapter 4. Oncology Informatics Market Segmentation & Impact Analysis
Continued…
